CN113230383A - Formula for repairing postpartum vagina injury and relaxation - Google Patents

Formula for repairing postpartum vagina injury and relaxation Download PDF

Info

Publication number
CN113230383A
CN113230383A CN202110504236.9A CN202110504236A CN113230383A CN 113230383 A CN113230383 A CN 113230383A CN 202110504236 A CN202110504236 A CN 202110504236A CN 113230383 A CN113230383 A CN 113230383A
Authority
CN
China
Prior art keywords
parts
vaginal
relaxation
repairing
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110504236.9A
Other languages
Chinese (zh)
Inventor
金亮
蔡文涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Tianen Pharmaceutical Technology Co ltd
Original Assignee
Guangzhou Tianen Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Tianen Pharmaceutical Technology Co ltd filed Critical Guangzhou Tianen Pharmaceutical Technology Co ltd
Priority to CN202110504236.9A priority Critical patent/CN113230383A/en
Publication of CN113230383A publication Critical patent/CN113230383A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

The invention provides a formula for repairing postpartum vagina injury and relaxation, belonging to the technical field of medicines and prepared from the following raw materials in parts by weight: 1 part of acidic fiber-forming peptide, 1 part of alkaline fiber-forming peptide, 2 parts of hydroxypropyl methylcellulose, 1 part of water-soluble starch, 2 parts of citric acid, 2 parts of sodium bicarbonate and 2 parts of polyethylene glycol; after the vaginal drug is administered, the vaginal drug is absorbed by vaginal mucosa, so that vaginal cells are full, damaged muscle tissues are repaired, vaginal elasticity is increased, and the vaginal mucosa is effectively protected.

Description

Formula for repairing postpartum vagina injury and relaxation
Technical Field
The invention relates to the technical field of medicines, in particular to a formula for repairing postpartum vagina injury and relaxation of women.
Background
At present, all products for female vaginal relaxation and postpartum pelvic floor muscle repair are physical methods, such as vaginal dumbbell and low-frequency electrical stimulation, and the treatment method is inconvenient; the medicine for treating and improving female vaginal relaxation and pelvic floor muscle relaxation by utilizing biological polypeptide is lacked.
Disclosure of Invention
Aiming at the technical defects, the invention aims to provide a formula for repairing the postpartum vagina injury and relaxation of women, which is absorbed by the vaginal mucosa after being administrated to the vagina, so that the vaginal cells are full, the damaged muscle tissue is repaired, the vaginal elasticity is increased, and the vaginal mucosa is effectively protected.
In order to solve the technical problems, the invention adopts the following technical scheme:
the formula for repairing postpartum vagina injury and relaxation is characterized by being prepared from the following raw materials in parts by weight:
1 part of acidic fiber forming peptide, 1 part of alkaline fiber forming peptide, 2 parts of hydroxypropyl methyl cellulose, 1 part of water-soluble starch, 2 parts of citric acid, 2 parts of sodium bicarbonate and 2 parts of polyethylene glycol.
The invention has the beneficial effects that: after the vaginal drug is administered, the vaginal drug is absorbed by vaginal mucosa, so that vaginal cells are full, damaged muscle tissues are repaired, vaginal elasticity is increased, and the vaginal mucosa is effectively protected.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
A formula for repairing postpartum vagina injury and relaxation is prepared from the following raw materials:
1 g of acidic fiber-forming peptide, 1 g of alkaline fiber-forming peptide, 2 g of hydroxypropyl methylcellulose, 1 g of water-soluble starch, 2 g of citric acid, 2 g of sodium bicarbonate and 2 g of polyethylene glycol.
The preparation method comprises the following steps:
separately performing acid-base granulation to obtain (A, B), drying, mixing, sieving, tabletting, and packaging; each tablet is 0.3g and 0.6 g.
The using method comprises the following steps:
the married or sexual life women take the tablets 1-2 times a day, and 7-10 days is a course of treatment.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.

Claims (1)

1. The formula for repairing postpartum vagina injury and relaxation is characterized by being prepared from the following raw materials in parts by weight:
1 part of acidic fiber forming peptide, 1 part of alkaline fiber forming peptide, 2 parts of hydroxypropyl methyl cellulose, 1 part of water-soluble starch, 2 parts of citric acid, 2 parts of sodium bicarbonate and 2 parts of polyethylene glycol.
CN202110504236.9A 2021-05-10 2021-05-10 Formula for repairing postpartum vagina injury and relaxation Pending CN113230383A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110504236.9A CN113230383A (en) 2021-05-10 2021-05-10 Formula for repairing postpartum vagina injury and relaxation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110504236.9A CN113230383A (en) 2021-05-10 2021-05-10 Formula for repairing postpartum vagina injury and relaxation

Publications (1)

Publication Number Publication Date
CN113230383A true CN113230383A (en) 2021-08-10

Family

ID=77132860

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110504236.9A Pending CN113230383A (en) 2021-05-10 2021-05-10 Formula for repairing postpartum vagina injury and relaxation

Country Status (1)

Country Link
CN (1) CN113230383A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103340837A (en) * 2013-07-08 2013-10-09 天津市聚星康华医药科技有限公司 Misoprostol vaginal effervescent tablets and preparation method thereof
CN111789937A (en) * 2020-07-06 2020-10-20 江苏艾特美科技有限公司 Bacteriostatic tablet with vagina tightening effect

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103340837A (en) * 2013-07-08 2013-10-09 天津市聚星康华医药科技有限公司 Misoprostol vaginal effervescent tablets and preparation method thereof
CN111789937A (en) * 2020-07-06 2020-10-20 江苏艾特美科技有限公司 Bacteriostatic tablet with vagina tightening effect

Similar Documents

Publication Publication Date Title
KR101337578B1 (en) Mucoadhesive xyloglucan―containing formulations useful in medical devices and in pharmaceutical formulations
EP3335739B1 (en) Mussel adhesive protein product and the use thereof for the treatment of inflammation of the mucosa
CN101648007B (en) Pharmaceutical composition for treating ulcus cruris and preparation method thereof
CN111748030A (en) Soluble non-denatured II type collagen and preparation method thereof
CN107754011A (en) A kind of liquid dressing for treating hemorrhoid and preparation method thereof
CN1872279B (en) Composition of medication for treating ulcer in the oral cavity, and preparation method
CN113230383A (en) Formula for repairing postpartum vagina injury and relaxation
CN105535867A (en) Antibacterial gel special for gynecology and preparation method thereof
CN102240260B (en) Medicament for treating colpoxerosis and preparation method thereof
RU2018125252A (en) Synergistic combination of pyrrolidone-carboxylic acid and / or its salts and hyaluronic acid and / or its salts for use in the treatment and / or prevention of dryness and irritation of mucous membranes
CN101020046A (en) Fast hymen Yegenerating repair medicine
CN103494792B (en) Compound phloroglucinol freeze-dried orally-disintegrating tablet and preparation method
CN100360141C (en) Calf-blood deprotein extract gel
KR100963611B1 (en) Eye composition comprising alginic acid based compounds and method of preparing the same
CN109289000A (en) It is a kind of to treat gynaecological imflammation gel and preparation method thereof
CN101648015A (en) Chinese medicinal composition for treating glaucoma and application thereof
WO2022037362A1 (en) Injection for treating herpes zoster
CN103432145A (en) Scar treatment external application western medicine composition preparation and application thereof
CN103191163B (en) Skin wound repairing pharmaceutical composition
CN108403619B (en) Medicinal gel preparation for treating skin burn caused by hydrofluoric acid
CN107616977A (en) A kind of compound preparation for treating antimigraine and preparation method thereof
CN113041213B (en) Rectal suppository containing hyaluronic acid and tetrahydropyrimidine and preparation method thereof
CN104434992A (en) Biological adhesive vaginal tablet of periplaneta americana extract and preparation method of biological adhesive vaginal tablet
WO2021179319A1 (en) Composition containing hydrolyzed chondroitin sulfate for preventing and treating osteoarthropathy
CN102641277A (en) Ointment for treating gynaopathy and dermatoses and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination